Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape

HIGHLIGHTS: What are the main findings? A definite diagnosis of invasive pulmonary aspergillosis is elusive in patients with severe COVID-19. Experimental and clinical data indicate that delayed initiation of antifungal therapy could be detrimental to IA. What is the implication of the main finding?...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsotsolis, Stavros, Kotoulas, Serafeim-Chrysovalantis, Lavrentieva, Athina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204408/
https://www.ncbi.nlm.nih.gov/pubmed/37218799
http://dx.doi.org/10.3390/arm91030016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204408/
https://www.ncbi.nlm.nih.gov/pubmed/37218799
http://dx.doi.org/10.3390/arm91030016

Ejemplares similares